Kleiner Perkins Caufield & Byers Xv, Llc - Net Worth and Insider Trading

Kleiner Perkins Caufield & Byers Xv, Llc Net Worth

The estimated net worth of Kleiner Perkins Caufield & Byers Xv, Llc is at least $6,989 dollars as of 2024-09-20. Kleiner Perkins Caufield & Byers Xv, Llc is the 10% Owner of Atara Biotherapeutics Inc and owns about 892 shares of Atara Biotherapeutics Inc (ATRA) stock worth over $6,989. Details can be seen in Kleiner Perkins Caufield & Byers Xv, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kleiner Perkins Caufield & Byers Xv, Llc has not made any transactions after 2014-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Kleiner Perkins Caufield & Byers Xv, Llc

Kleiner Perkins Caufield & Byers Xv, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kleiner Perkins Caufield & Byers Xv, Llc owns 2 companies in total, including RAPT Therapeutics Inc (RAPT) , and Atara Biotherapeutics Inc (ATRA) .

Click here to see the complete history of Kleiner Perkins Caufield & Byers Xv, Llc’s form 4 insider trades.

Insider Ownership Summary of Kleiner Perkins Caufield & Byers Xv, Llc

Ticker	Comapny	Transaction Date	Type of Owner
RAPT	RAPT Therapeutics Inc	2020-07-14	10 percent owner
ATRA	Atara Biotherapeutics Inc	2014-10-15	10 percent owner

Kleiner Perkins Caufield & Byers Xv, Llc Latest Holdings Summary

Kleiner Perkins Caufield & Byers Xv, Llc currently owns a total of 1 stock. Kleiner Perkins Caufield & Byers Xv, Llc owns 892 shares of Atara Biotherapeutics Inc (ATRA) as of October 15, 2014, with a value of $6,989.

Latest Holdings of Kleiner Perkins Caufield & Byers Xv, Llc

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ATRA	Atara Biotherapeutics Inc	2014-10-15	892	7.84	6,989

Holding Weightings of Kleiner Perkins Caufield & Byers Xv, Llc

Kleiner Perkins Caufield & Byers Xv, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Kleiner Perkins Caufield & Byers Xv, Llc has made a total of 0 transactions in Atara Biotherapeutics Inc (ATRA) over the past 5 years. The most-recent trade in Atara Biotherapeutics Inc is the sale of 0 shares on October 15, 2014, which brought Kleiner Perkins Caufield & Byers Xv, Llc around $0.

Insider Trading History of Kleiner Perkins Caufield & Byers Xv, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kleiner Perkins Caufield & Byers Xv, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kleiner Perkins Caufield & Byers Xv, Llc Ownership Network

Ownership Network List of Kleiner Perkins Caufield & Byers Xv, Llc

No Data

Ownership Network Relation of Kleiner Perkins Caufield & Byers Xv, Llc

Kleiner Perkins Caufield & Byers Xv, Llc Owned Company Details

What does RAPT Therapeutics Inc do?

Who are the key executives at RAPT Therapeutics Inc?

Kleiner Perkins Caufield & Byers Xv, Llc is the 10 percent owner of RAPT Therapeutics Inc. Other key executives at RAPT Therapeutics Inc include Chief Scientific Officer Dirk G. Brockstedt , Chief Medical Officer William Ho , and 10 percent owner Column Group Ii, Lp .

RAPT Therapeutics Inc (RAPT) Insider Trades Summary

Over the past 18 months, Kleiner Perkins Caufield & Byers Xv, Llc made no insider transaction in RAPT Therapeutics Inc (RAPT). Other recent insider transactions involving RAPT Therapeutics Inc (RAPT) include a net sale of 14,000 shares made by William Ho , and a net sale of 898 shares made by Dirk G. Brockstedt .

In summary, during the past 3 months, insiders sold 0 shares of RAPT Therapeutics Inc (RAPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,898 shares of RAPT Therapeutics Inc (RAPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 14,898 shares.

RAPT Therapeutics Inc (RAPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

RAPT Therapeutics Inc Insider Transactions

No Available Data

Kleiner Perkins Caufield & Byers Xv, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Kleiner Perkins Caufield & Byers Xv, Llc. You might contact Kleiner Perkins Caufield & Byers Xv, Llc via mailing address: 2750 Sand Hill Road, Menlo Park Ca 94025.

Discussions on Kleiner Perkins Caufield & Byers Xv, Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.

Kleiner Perkins Caufield & Byers Xv, Llc - Net Worth and Insider Trading